One of the most exciting recent breakthroughs from research funded by the National Institute of Mental Health (NIMH) is the development of a fast-acting medication for treatment-resistant depression based on ketamine. This treatment is bringing new hope to people and families affected by major depression.
from NIMH News Feed https://ift.tt/33hadx2
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment